U.S. markets open in 5 hours 40 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
119.78-1.80 (-1.48%)
At close: 4:02PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close121.58
Bid0.00 x 800
Ask0.00 x 1200
Day's Range119.66 - 122.36
52 Week Range61.61 - 128.54
Avg. Volume4,996,985
Market Cap212.194B
Beta (5Y Monthly)0.73
PE Ratio (TTM)47.85
EPS (TTM)2.50
Earnings DateApr 14, 2021 - Apr 19, 2021
Forward Dividend & Yield1.80 (1.50%)
Ex-Dividend DateApr 14, 2021
1y Target Est134.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
21% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 3 Great Stocks for Low-Risk Investors
    Motley Fool

    3 Great Stocks for Low-Risk Investors

    Abbott Laboratories (NYSE: ABT) is one of the most consistent growth stocks you'll find in the sector. The highly diversified seller of medical devices, diagnostics, pharmaceuticals for emerging market countries, and nutrition products puts together one solid quarter after another and hasn't had an earnings disappointment in over a decade. Abbott's fourth-quarter results got a big boost from COVID-19 testing.

  • Why Is Abbott (ABT) Up 1% Since Last Earnings Report?

    Why Is Abbott (ABT) Up 1% Since Last Earnings Report?

    Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall

    Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall

    Teleflex (TFX) witnesses significant sequential improvement in segmental performance during the fourth quarter on gradual recovery of the economy.